Skip to main content
. 2018 Oct 26;1(6):e183750. doi: 10.1001/jamanetworkopen.2018.3750

Table 2. Clinical Outcomes of Focused Psychotropic Medication Review.

Source Clinical Outcome Measure Result
Randomized Clinical Trials
Ballard et al,23 2016 Neuropsychiatric symptoms Neuropsychiatric Inventory Difference between intervention and control groups favors control 7.37 (95% CI, 1.53-13.22; P = .02)a
Agitation Cohen-Mansfield Agitation Inventory Difference between intervention and control groups: 4.60 (95% CI, −1.43 to 10.63; P = .13)
Depression Cornell Scale for Depression in Dementia Difference between intervention and control groups: −1.70 (95% CI, −4.29 to 0.90; P = .19)
Mortality Death OR, 0.67 (95% CI, 0.39-1.14; P = .15)
Ballard et al,24 2017 Proxy health-related quality of life DEMQOL: Dementia-Related Quality of Life measure Difference between intervention and control groups: 4.54 (95% CI, −9.26 to 0.19; P = .06)
Moncrieff et al,25 2016 Clinical symptoms of severe mental illness Brief Positive and Negative Syndrome Scale Difference between intervention and control groups: 0.13 (95% CI, −2.20 to 2.48)
Antipsychotic drug adverse effects Liverpool University Neuroleptic Side-Effect Rating Scale Difference between intervention and control groups: −0.42 (95% CI, −8.12 to 7.29)
Medication adherence Medication Adherence Questionnaire Difference between intervention and control groups favors intervention: −0.44 (95% CI, −0.76 to −0.11)a
Confidence in participating in clinical discussions and decisions Decision Self-Efficacy Scale Mean difference between intervention and control group: −4.16 (95% CI, −9.81 to 1.49)
Patient satisfaction Client Satisfaction Questionnaire Difference between intervention and control groups: −0.29 (95% CI, −3.04 to 2.45)
Attitude toward medication Drug Attitude Inventory Difference between intervention and control groups: 1.65 (95% CI, −0.09 to 3.40)
Jordan et al,26 2015 Drug-related problems addressed (adverse effects) Counts Difference between intervention and control groups favors intervention: 3.34 (95% CI, 2.57-4.11; P < .001)a
Functional ability Bristol Activities of Daily Living Scale Mean difference between intervention and control group: 0.45 (95% CI, −0.47 to 0.93; P = .52)
Dementia psychopathology Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia Difference between intervention and control groups: 4.67 (95% CI, −0.04 to 2.78; P = .06)
Patterson et al,27 2010 Falls Rate 16.3 falls/100 person-mo in intervention group vs 11.4 falls/100 person-months in control group (P = .09)
Before-After Study Designs
Gallimore et al,42 2016 Up-to-date laboratory monitoring Proportion of participants 54.1% (before); 72.1% (after) (P < .001)a
At risk of drug-drug interaction Proportion of participants 43.8% (before); 24.3% (after) (P < .001)a
Movement adverse effect monitoring Proportion of participants 75.0% (before); 63.5% (after) (P = .21)
Branford,29 1996 Clinical presentation Subjective assessment 25% undergoing medication change had “good” outcome, 43% “poor” outcome, 32% “unclear” outcome
Jauernig et al,34 1995 Challenging behavior Frequency counts Mean daily frequency of challenging behavior lower after the intervention than at baseline in 80%
Bisconer et al,28 1995 Challenging behavior Frequency counts Mean decrease in challenging behavior after intervention
Reported medication adverse effects Proportion of participants (n = 11 [14%]) before intervention, (n = 8 [10%]) after intervention
Glaser et al,32 1986 Aggressive challenging behavior Frequency counts No significant difference between intervention and control groupsb
Inoue,33 1982 Clinical presentation Subjective assessment “Positive change” in 96.5% receiving intervention, “negative” change in 3.5%
Ellenor et al,30 1977 Challenging behavior Aberrant Behavior Checklist “Slight increase” in challenging behavior but no significant difference between intervention and control groupb

Abbreviation: OR, odds ratio.

a

Results statistically significant at P < .05.

b

These studies had control groups only for the secondary outcome of change in challenging behavior.